Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
The return on assets (ROA) is N/A as of Tuesday, October 6, 2026.
RETURN ON ASSETS (ROA)
N/A
Braveheart Bio, Inc.
Market Cap
$1.53B
Return on Assets (ROA)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.52B
Return on Assets (ROA)
-16.72%
TTM Avg
-18.71%
3Y Avg
-15.50%
5Y Avg
-12.14%
Market Cap
$1.52B
Return on Assets (ROA)
20.98%
TTM Avg
9.19%
3Y Avg
12.55%
5Y Avg
16.89%
Market Cap
$1.52B
Return on Assets (ROA)
10.96%
TTM Avg
-5.00%
3Y Avg
-12.25%
5Y Avg
-27.07%
Market Cap
$1.46B
Return on Assets (ROA)
61.75%
TTM Avg
-16.82%
3Y Avg
-22.73%
5Y Avg
-17.45%
Market Cap
$1.45B
Return on Assets (ROA)
14.98%
TTM Avg
6.07%
3Y Avg
5.42%
5Y Avg
6.72%
Market Cap
$1.56B
Return on Assets (ROA)
-4.89%
TTM Avg
-0.43%
3Y Avg
-0.87%
5Y Avg
-1.37%
Market Cap
$1.44B
Return on Assets (ROA)
-32.81%
TTM Avg
-32.81%
3Y Avg
-32.81%
5Y Avg
-32.81%
Market Cap
$1.40B
Return on Assets (ROA)
-21.52%
TTM Avg
-21.52%
3Y Avg
-21.52%
5Y Avg
-21.52%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | $1.53B | N/A | N/A | N/A | N/A |
| GH Research PLC (GHRS)vs › | $1.52B | -16.72% | -18.71% | -15.50% | -12.14% |
| Innoviva, Inc. (INVA)vs › | $1.52B | 20.98% | 9.19% | 12.55% | 16.89% |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.52B | 10.96% | -5.00% | -12.25% | -27.07% |
| AnaptysBio, Inc. (ANAB)vs › | $1.46B | 61.75% | -16.82% | -22.73% | -17.45% |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.45B | 14.98% | 6.07% | 5.42% | 6.72% |
| Certara, Inc. (CERT)vs › | $1.56B | -4.89% | -0.43% | -0.87% | -1.37% |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.44B | -32.81% | -32.81% | -32.81% | -32.81% |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.40B | -21.52% | -21.52% | -21.52% | -21.52% |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.39B | -89.60% | 418.97% | 177.41% | 100.38% |
ROA
N/A
ROE
N/A
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
